IMMUNE PHARMACEUTICALS INC Note Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promissory Note between Immune Pharmaceuticals Inc. and Investor (October 9, 2018)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2018
Convertible Promissory Note between Immune Pharmaceuticals Inc. and Power Up Lending Group Ltd. dated September 12, 2018
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2018
Senior Secured Convertible Promissory Note between Immune Pharmaceuticals, Inc. and MEF I, L.P. (July 7, 2017)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
6% Convertible Note Agreement between Immune Pharmaceuticals, Inc. and EMA Financial, LLC dated April 10, 2017
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Immune Pharmaceuticals Inc. $1,050,000 Convertible Note Agreement with HLHW IV, LLC (November 17, 2016)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Promissory Note between Immune Pharmaceuticals, Inc. and Lender (2016)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
8% Senior Note Due 2006 between EpiCept Corporation and Sanders Opportunity Fund (Institutional), L.P.
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
8% Senior Note Due 2006 between EpiCept Corporation and Sanders Opportunity Fund, L.P.
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
Amended and Restated 8% Senior Note Due 2006 between EpiCept Corporation and Regulation S Purchasers
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
Amended and Restated 8% Senior Note Due 2006 between EpiCept Corporation and TVM IV GmbH & Co. KG
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
Amended and Restated Note Purchase Agreement by and among EpiCept Corporation and Purchasers (August 26, 2005)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
Fourth Amended and Restated Convertible Term Note between EpiCept Corporation and Payee (Due April 30, 2005)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
EpiCept Corporation 8% Senior Note Due 2006 Issued Pursuant to Note Purchase Agreement
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
Note Purchase Agreement between EpiCept Corporation and Purchasers Dated March 3, 2005
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005
Third Amended and Restated Convertible Term Note between EpiCept Corporation and [Holder] (Due April 30, 2005)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
DE
2005